Literature DB >> 12934186

Prophylactic and therapeutic effects of phthalocyanine tetrasulfonate in scrapie-infected mice.

Suzette A Priola1, Anne Raines, Winslow Caughey.   

Abstract

The transmissible spongiform encephalopathy (TSE) diseases are rare, neurodegenerative diseases that include scrapie in sheep, bovine spongiform encephalopathy, and Creutzfeldt-Jakob disease in humans. There are no effective treatments available for clinical use in humans. We now demonstrate that, in 2 different rodent models of scrapie, multiple pretreatments with the cyclic tetrapyrrole phthalocyanine tetrasulfonate (PcTS) were as effective at delaying disease as multiple treatments starting at the time of infection. At low doses of scrapie infectivity, PcTS also protected some mice from peripheral scrapie infection, even if treatment was initiated several weeks after infection. Furthermore, PcTS completely inactivated low levels of scrapie infectivity when incubated with the infectious inoculum. Thus, PcTS has a broad range of antiscrapie activities. These findings suggest that cyclic tetrapyrroles may be useful both prophylactically and therapeutically against TSE diseases in vivo, as well as for inactivation of TSE infectivity suspended in solution.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12934186     DOI: 10.1086/377310

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Inhibition of protease-resistant prion protein formation in a transformed deer cell line infected with chronic wasting disease.

Authors:  Gregory J Raymond; Emily A Olsen; Kil Sun Lee; Lynne D Raymond; P Kruger Bryant; Gerald S Baron; Winslow S Caughey; David A Kocisko; Linda E McHolland; Cynthia Favara; Jan P M Langeveld; Fred G van Zijderveld; Richard T Mayer; Michael W Miller; Elizabeth S Williams; Byron Caughey
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  A porphyrin increases survival time of mice after intracerebral prion infection.

Authors:  David A Kocisko; Winslow S Caughey; Richard E Race; Grant Roper; Byron Caughey; John D Morrey
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Assessment of prospective preventive therapies for chronic wasting disease in mule deer.

Authors:  Lisa L Wolfe; David A Kocisko; Byron Caughey; Michael W Miller
Journal:  J Wildl Dis       Date:  2012-04       Impact factor: 1.535

Review 4.  Recent advances in prion chemotherapeutics.

Authors:  Valerie L Sim; Byron Caughey
Journal:  Infect Disord Drug Targets       Date:  2009-02

5.  Cyclic tetrapyrrole sulfonation, metals, and oligomerization in antiprion activity.

Authors:  Winslow S Caughey; Suzette A Priola; David A Kocisko; Lynne D Raymond; Anne Ward; Byron Caughey
Journal:  Antimicrob Agents Chemother       Date:  2007-08-20       Impact factor: 5.191

6.  Prion Strains Differ in Susceptibility to Photodynamic Oxidation.

Authors:  Marie Kostelanska; Karel Holada
Journal:  Molecules       Date:  2022-01-18       Impact factor: 4.411

7.  Discovery of a novel, monocationic, small-molecule inhibitor of scrapie prion accumulation in cultured sheep microglia and Rov cells.

Authors:  James B Stanton; David A Schneider; Kelcey D Dinkel; Bethany F Balmer; Timothy V Baszler; Bruce A Mathison; David W Boykin; Arvind Kumar
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.